Trial · NCT00076752
Outcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Relapse-free Complete Clinical Response | 60 months | Ninth participant was taken off study before proceeding with transplant per principal investigator due to decision to put study on hold. | Months | MEDIAN |
| SECONDARY | Number of Participants With Adverse Events | 18 months | participants | NUMBER | |
| SECONDARY | Anti-Nuclear Antibody | Day -7, day 0, 1 3, and 6 months, 1 year, 18 months, 2 years and 3 years. | One participant was enrolled but the study was closed before the patient could be treated. | EU | MEAN |
| SECONDARY | Extractable Nuclear Antigen (ENA) | Day -7, day 0, 1 3, and 6 months, 1 year, 18 months, 2 years and 3 years. | One participant was enrolled but the study was closed before the patient could be treated. | EU | MEAN |
| SECONDARY | Anti-Double Stranded Deoxyribonucleic Acid (DNA) Antibody | Day -7, day 0, 1 3, and 6 months, 1 year, 18 months, 2 years and 3 years. | One participant was enrolled but the study was closed before the patient could be treated. | IU | MEAN |
| SECONDARY | Anti-Smith-Ribonuclear Protein Antibody | Day -7, day 0, 1 3, and 6 months, 1 year, 18 months and 2 years. | One participant was enrolled but the study was closed before the patient could be treated. | EU | MEAN |
| SECONDARY | White Blood Cells | Day -7, day 0, 1 3, and 6 months, 1 year, 18 months, 2 years and 3 years. | One participant was enrolled but the study was closed before the patient could be treated. | K/uL | MEAN |
| SECONDARY | Absolute Neutrophil Count | Day -7, day 0, 1 3, and 6 months, 1 year, 18 months, 2 years and 3 years. | One participant was enrolled but the study was closed before the patient could be treated. | K/uL | MEAN |
| SECONDARY | Absolute Lymphocyte Count | Day -7, day 0, 1 3, and 6 months, 1 year, 18 months, 2 years and 3 years. | One participant was enrolled but the study was closed before the patient could be treated. | K/uL | MEAN |
| SECONDARY | Platelet Count | Day -7, day 0, 1 3, and 6 months, 1 year, 18 months, 2 years and 3 years. | One participant was enrolled but the study was closed before the patient could be treated. | K/uL | MEAN |
| SECONDARY | Cluster of Differentiation 3 (CD3) + Cells | Day 0, 1 month, 3 months, 6 months, 1 year and 2 years. | One participant was enrolled but the study was closed before the patient could be treated. | cells/mL^3 | MEAN |
| SECONDARY | Cluster of Differentiation 4 (CD4) + Cells | Day 0, 1 month, 3 months, 6 months, 1 year and 2 years. | One participant was enrolled but the study was closed before the patient could be treated. | cells/mL^3 | MEAN |
| SECONDARY | Cluster of Differentiation 8 (CD8) + Cells | Day 0, 1 month, 3 months, 6 months, 1 year and 2 years. | One participant was enrolled but the study was closed before the patient could be treated. | cells/mL^3 | MEAN |
| SECONDARY | Cluster of Differentiation 19 (CD19) + Cells | Day 0, 1 month, 3 months, 6 months, 1 year and 2 years. | One participant was enrolled but the study was closed before the patient could be treated. | cells/mL^3 | MEAN |
| SECONDARY | Natural Killer Cells | Day 0, 1 month, 3 months, 6 months, 1 year and 2 years. | One participant was enrolled but the study was closed before the patient could be treated. | cells/mL^3 | MEAN |
| SECONDARY | Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) | Day -7, day 0, 1 month, 3 months, 6 months, 1 year, 18 months, 2 years and 3 years. | One participant was enrolled but the study was closed before the patient could be treated. | scores on a scale. | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00076752/outcomes